Xtant Medical (NYSEAMERICAN:XTNT) Shares Pass Above 200-Day Moving Average – Here’s Why

Shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $0.55. Xtant Medical shares last traded at $0.52, with a volume of 27,928 shares traded.

Analyst Ratings Changes

Separately, Craig Hallum set a $1.50 target price on Xtant Medical and gave the stock a “buy” rating in a report on Friday, October 18th.

Xtant Medical Stock Up 0.6 %

The firm has a market cap of $72.29 million, a price-to-earnings ratio of -4.00 and a beta of 0.33. The company has a quick ratio of 0.88, a current ratio of 2.12 and a debt-to-equity ratio of 0.42.

Xtant Medical (NYSEAMERICAN:XTNT) last issued its earnings results on Tuesday, November 12th. The medical device company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Xtant Medical had a negative return on equity of 37.07% and a negative net margin of 15.45%. The firm had revenue of $27.94 million for the quarter.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Xtant Medical stock. Evernest Financial Advisors LLC bought a new stake in Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 40,000 shares of the medical device company’s stock, valued at approximately $27,000. 69.33% of the stock is currently owned by hedge funds and other institutional investors.

About Xtant Medical

Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.